Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Asahi Kasei Corporation to Fully Acquire Asahi Kasei Kuraray Medical Co., Ltd.
Asahi Kasei Corporation announced that it has decided to purchase a 7% stake of Asahi Kasei Kuraray Medical Co., Ltd., which was a joint venture established by Asahi Kasei Corporation and Kuraray Co., Ltd, from Kuraray Co., Ltd, on April 1, 2012. After this, Asahi Kasei Corporation will hold a 100% stake in Asahi Kasei Kuraray Medical Co., Ltd.
Latest Developments for Asahi Kasei Corp
- R&I Affirms Rating on Asahi Kasei Corp at "AA-"; Rating Outlook Stable
- Asahi Kasei Corp Completes Subsequent Offering Period For ZOLL Medical Corp
- Asahi Kasei Corporation Commences Tender Offer For ZOLL Medical Corporation
- Asahi Kasei Corporation To Buy ZOLL Medical Corporation For Up To JPY100 Billion-DJ
Latest Key Developments in Chemicals
- Share this
- Link this
- Digg this
Follow Reuters